Core Viewpoint - Kellanova is expected to report a decline in quarterly earnings and revenues, with analysts predicting earnings of $0.98 per share and revenues of $3.13 billion, reflecting decreases of 3% and 2.1% year-over-year respectively [1] Financial Estimates - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating analysts' reassessment of their forecasts [1] - Analysts project 'Net sales- Latin America' at $285.85 million, a decrease of 9% from the prior-year quarter [4] - 'Net sales- Europe' is estimated at $586.27 million, reflecting a decline of 2.1% year-over-year [4] - 'Net sales- North America' is expected to reach $1.66 billion, indicating a decrease of 1.5% from the previous year [4] - 'Net sales- AMEA' is forecasted at $571.91 million, suggesting a year-over-year decline of 4.7% [5] Growth Metrics - Total reported growth for Latin America is expected to be -8.9%, down from 10.9% in the same quarter last year [5] - 'Net sales - Latin America - Forex impact - YoY change' is projected at -12.4%, compared to 5.7% a year ago [5] - 'Net sales - AMEA - Price / mix impact - YoY change' is estimated at 11.7%, down from 19.4% in the same quarter last year [6] - 'Net sales - Europe - Price / mix impact - YoY change' is expected to be 2.3%, compared to 9.5% a year ago [6] - 'Net sales - North America - Price / mix impact - YoY change' stands at -0.8%, down from 4.8% year-over-year [7] - 'Net sales - Consolidated - price / mix impact - YoY change' is projected at 2.4%, compared to 8.5% in the previous year [7] Profitability Estimates - 'Adjusted Operating Profit / (loss)- Latin America' is expected to be $20.94 million, down from $25 million year-over-year [8] - 'Adjusted Operating Profit / (loss)- Europe' is projected at $98.12 million, slightly up from $98 million in the same quarter last year [8] Stock Performance - Kellanova shares have experienced a change of -0.1% over the past month, compared to a -0.8% move in the Zacks S&P 500 composite [9] - The company holds a Zacks Rank 4 (Sell), indicating expectations of underperformance relative to the overall market [9]
Curious about Kellanova (K) Q1 Performance? Explore Wall Street Estimates for Key Metrics